GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Resources (Shanghai) Co Ltd (SZSE:301230) » Definitions » 3-Year Revenue Growth Rate

Pharma Resources (Shanghai) Co (SZSE:301230) 3-Year Revenue Growth Rate : 8.50% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Pharma Resources (Shanghai) Co 3-Year Revenue Growth Rate?

Pharma Resources (Shanghai) Co's Revenue per Share for the three months ended in Jun. 2024 was ¥1.03.

During the past 12 months, Pharma Resources (Shanghai) Co's average Revenue per Share Growth Rate was -10.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 8.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 22.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Pharma Resources (Shanghai) Co was 49.60% per year. The lowest was 8.50% per year. And the median was 24.80% per year.


Competitive Comparison of Pharma Resources (Shanghai) Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Pharma Resources (Shanghai) Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Resources (Shanghai) Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Resources (Shanghai) Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Pharma Resources (Shanghai) Co's 3-Year Revenue Growth Rate falls into.



Pharma Resources (Shanghai) Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Pharma Resources (Shanghai) Co  (SZSE:301230) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Pharma Resources (Shanghai) Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Pharma Resources (Shanghai) Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Resources (Shanghai) Co Business Description

Traded in Other Exchanges
N/A
Address
No. 315, Qingda Road, Building 23, Pudong New Area, Shanghai, CHN, 201201
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.

Pharma Resources (Shanghai) Co Headlines

No Headlines